Differences Between Peptic Ulcer Disease and Gastritis
Peptic ulcer disease represents a deeper mucosal defect with erosion through the muscularis mucosae, while gastritis is inflammation of the gastric mucosa without full-thickness ulceration.
Pathologic Distinction
Gastritis is defined as chronic inflammation of the gastric mucosa that may progress to atrophic changes with loss of gastric glands, with or without metaplasia 1. The inflammatory process remains confined to the mucosal layer without creating a discrete crater 1.
Peptic ulcer disease occurs when acid-peptic damage penetrates through the gastro-duodenal mucosa, creating mucosal erosion that exposes underlying tissues to digestive secretions 2. This represents a break in the mucosal barrier extending beyond the muscularis mucosae, creating a distinct ulcer crater 2.
Clinical Presentation and Complications
Gastritis typically presents with more diffuse symptoms and rarely causes life-threatening complications on its own 1. The inflammation can be superficial or atrophic and may persist chronically without acute deterioration 3.
Peptic ulcer disease has a lifetime prevalence of 5-10% in the general population and carries significant risk of complications 2. Complications occur in 10-20% of peptic ulcer patients and include:
Relationship and Natural History
Gastritis appears to be the underlying disease process, with peptic ulceration representing a secondary phenomenon 3. Key evidence:
- Gastritis associated with chronic gastric ulcer is usually widespread in ulcers of the gastric body, whereas it is more localized in prepyloric ulcers 3
- Superficial or atrophic gastritis persists or worsens after ulcer healing, whether treatment is medical or surgical 3
- Gastritis tends to be lifelong with rare spontaneous healing 4
Topographic Patterns
The distribution of gastritis influences ulcer risk 4:
- Chronic antral gastritis or pangastritis: Associated with peptic ulcer disease, particularly duodenal ulcer (incidence exceeding 20% after 10 years) 4
- Chronic corpus gastritis with severe atrophy: Peptic ulcers (both gastric and duodenal) are extremely rare in this pattern 4
- Antral gastritis occurs in 94-96% of both duodenal and gastric ulcer patients, but severe antral inflammation is more common in gastric ulcer (43%) than duodenal ulcer (17%) 5
Common Etiologic Factors
Both conditions share major risk factors 2, 6:
- Helicobacter pylori infection: Worldwide prevalence approximately 50%, highest in developing countries 2. With very few exceptions, gastritis is associated with H. pylori presence 4
- NSAID use: Extensive use has changed the epidemiology of both conditions 2
- Alcohol and smoking abuse: Contributing factors to both gastritis and ulcer disease 2
Diagnostic Approach
Gastritis diagnosis: Requires histopathologic confirmation 1. Endoscopic features include pale mucosa, increased vascular visibility, loss of gastric folds, and if intestinal metaplasia is present, light blue crests and white opaque fields 1. Biopsies from body and antrum should be obtained in separately labeled jars 1.
Peptic ulcer diagnosis: In suspected perforation, CT scan is recommended as first-line imaging (or chest/abdominal X-ray if CT unavailable) 2. Laboratory studies and arterial blood gas analysis are recommended 2. Endoscopy within 24 hours is suggested for bleeding ulcers 7.
Management Implications
Gastritis: Focus on H. pylori eradication if positive, surveillance for progression to atrophy/metaplasia, and assessment for autoimmune gastritis with appropriate laboratory testing 1
Peptic ulcer disease: Requires more aggressive intervention including endoscopic therapy for bleeding ulcers with active bleeding or visible vessels 7, surgical consultation for perforation 2, high-dose PPI therapy after endoscopic hemostasis 7, and H. pylori eradication 8
Key Clinical Pitfall
The presence of intestinal metaplasia on gastric histology almost invariably implies atrophic gastritis 1. This is often not distinctly noted on histopathologic reports, requiring coordinated effort between gastroenterologists and pathologists to document extent and severity 1.